Atai Life Sciences N.V.
biopharmaceutical company aiming to transform the treatment of mental health disorders
AI Overview
With $165K in lobbying spend across 7 quarterly filings, Atai Life Sciences N.V is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $115K |
| 2022 | $50K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Atai Life Sciences N.V. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy
DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
DEA Restrictions on Psychedelics
Coverage and Reimbursement for Mental Health Services
Company Drug Development Updates
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.